Pacer Advisors, Inc. Ardelyx, Inc. Transaction History
Pacer Advisors, Inc.
- $38.6 Billion
- Q1 2024
A detailed history of Pacer Advisors, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 4,909 shares of ARDX stock, worth $25,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,909Holding current value
$25,919% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ARDX
# of Institutions
197Shares Held
140MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$116 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$90.3 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$74.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$70.7 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$36 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $816M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...